Independent Optometry vs Private Equity: Competing Without Selling

Every independent optometrist has watched it happen nearby: a respected practice sells to a private-equity-backed group, the founder's name stays on the door, and the recruiting emails start arriving. PE consolidation has moved through eye care for a decade — ophthalmology first, optometry increasingly — and it forces a question every owner should answer on purpose: sell, or compete? This is the competing playbook.

Respect what the consolidators do well

Pretending PE groups are merely soulless is a losing scouting report. Their real advantages: negotiated payer rates and vendor pricing at scale, centralized billing and credentialing, recruiting pipelines with signing bonuses, marketing budgets, and capital for equipment and locations. Where they're structurally weak is just as real: physician and staff turnover that erodes patient relationships, corporate metrics that squeeze visit length, distant call centers replacing the front desk that knew Mrs. Alvarez by voice, and EBITDA math that treats care as cost. Every one of those weaknesses maps to an independent strength — if you operationalize it.

Compete on the relationship — systematically

'We're more personal' only wins if it's engineered: same-doctor continuity, retention machinery that notices when patients drift, same-day access the call center can't match, and a Google profile whose review stream reads like a neighborhood, not a chain. Deepen the clinical moat with services corporate templates handle poorly: medical eye care, glaucoma management, specialty lenses, and the pediatric line that captures whole families.

Close the efficiency gap without the corporate office

The consolidators' genuine edge is back-office scale — and it's the most closable gap in the fight. Their centralized billing team, credentialing department, and recall call center are, functionally, shared administrative labor. An independent gets the same leverage by delegation: a trained eye care virtual assistant at a flat $10/hour runs the billing follow-up, insurance verification, recall lists, review management, and reporting that PE groups centralize — without the practice surrendering its name, culture, or clinical autonomy. Add a buying group for frames and lenses, and an independent optometry office runs corporate-grade operations at independent scale. (Independent ophthalmology groups facing the same wave use the same formula.)

If you ever do entertain an offer

Compete-versus-sell is a personal decision as much as a financial one. If an offer arrives, take it seriously and skeptically: valuation multiples come with earn-outs, employment terms, and control provisions that deserve a healthcare attorney and accountant — not a decision made from burnout. Notably, the practices that compete best from strength are also the ones that command the best terms if they ever sell: clean books, documented systems, strong operational fundamentals. Build the practice that doesn't need to sell, and every option stays yours.

The long game

Consolidation waves crest; patient needs don't. Eye care remains a relationship business delivered locally, one exam at a time — which is precisely the terrain where a well-run independent, freed from administrative drag and competing deliberately, holds ground that money alone can't buy.